Adipokine/hepatokines profiling of fatty liver in adolescents and young adults: cross-sectional and prospective analyses of the BCAMS study
Hepatology International · 2025
DOI: 10.1007/s12072-024-10736-9 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Hepatology International, 2025. Verfasst von Xinghao Yi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, NHC Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Aca…. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Adipokines, Metabolic Syndrome. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Capital's Funds for Health Improvement and Research, CAMS Innovation Fund for Medical Sciences.
Abstract (Originalsprache)
OBJECTIVE: The underlying connections between obesity and non-alcoholic fatty liver disease (NAFLD) are not fully understood. One potential link might be the imbalanced adipokines and hepatokines. We aimed to explore the associations between specific adipokines/hepatokines and NAFLD in Chinese youth and to determine how these biomarkers mediate the obesity-NAFLD relationship. METHODS: We analyzed data from the 10-year follow-up visit of the Beijing Children and Adolescents Metabolic Syndrome (BCAMS) study (n = 509; mean age = 20.2 years) for a comprehensive metabolic risk assessment, including liver ultrasound and plasma measurements of adiponectin, leptin, fibroblast growth factor 21 (FGF21), retinol-binding protein 4 (RBP4), and angiopoietin-like protein 8 (ANGPTL8). Longitudinal analysis was performed on a subgroup (n = 307), with complete baseline (mean age = 12.2 years) and follow-up data. Mediation models assessed how obesity at baseline and follow-up influence NAFLD through these biomarkers. RESULTS: Participants with NAFLD exhibited a high prevalence of central obesity (90.9%). Both cross-sectional and prospective analyses identified increased RBP4, FGF21, leptin, and decreased adiponectin levels as significant predictors of NAFLD. More adipokine/hepatokine abnormalities were linked to higher NAFLD risk. Furthermore, ratios reflecting adipokine/hepatokine imbalances, including leptin/adiponectin, FGF21/adiponectin, and RBP4/adiponectin, demonstrated stepwise changes correlating with NAFLD severity (all p < 0.05). Mediation analysis indicated that these four adipokines/hepatokines accounted for approximately 72.4% of the central obesity-NAFLD relationship and 80.1% in the subgroup analysis using baseline childhood data. CONCLUSIONS: Dysregulated adipokines/hepatokines may explain the onset or progression of obesity-related NAFLD in youths. Higher RBP4, FGF21 and leptin, alongside lower adiponectin, could serve as early biomarkers for NAFLD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, NHC Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, 100730, People's Republic of China.
- Department of Endocrinology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, 100043, People's Republic of China.
- Department of Endocrinology, NHC Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, 100730, People's Republic of China.…
- Department of Endocrinology, Xuanwu Hospital, Capital Medical University, Beijing, 100053, People's Republic of China. gaoshanmw@163.com.
Förderung
- National Natural Science Foundation of China
- Capital's Funds for Health Improvement and Research
- CAMS Innovation Fund for Medical Sciences
- High-level Hospital Construction Project of Guangdong Provincial People's Hospital
- Key Program of Beijing Municipal Science & Technology Commission
Zitieren
APA
Yi, X., Han, L., Li, L., Zhu, H., Li, M., & Gao, S. (2025). Adipokine/hepatokines profiling of fatty liver in adolescents and young adults: cross-sectional and prospective analyses of the BCAMS study. Hepatology International. https://doi.org/10.1007/s12072-024-10736-9
Vancouver
Yi X, Han L, Li L, Zhu H, Li M, Gao S. Adipokine/hepatokines profiling of fatty liver in adolescents and young adults: cross-sectional and prospective analyses of the BCAMS study. Hepatology International. 2025. doi:10.1007/s12072-024-10736-9
BibTeX
@article{Yi2025,
author = {Yi, Xinghao and Han, Lanwen and Li, Lianxia and Zhu, Haoxue and Li, Ming and Gao, Shan},
title = {Adipokine/hepatokines profiling of fatty liver in adolescents and young adults: cross-sectional and prospective analyses of the BCAMS study},
journal = {Hepatology International},
year = {2025},
doi = {10.1007/s12072-024-10736-9}
}
EUVIMED